Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|December 5, 2012
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replicationP Recordon-Pinson, S Raymond, P Bellecave, et al.Antimicrobial Agents and Chemotherapy|April 25, 2012
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 studyC Clavel, G Peytavin, R Tubiana, et al.HIV Clinical Trials|November 9, 2012
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra studyL Schneider, N Ktorza, S Fourati, et al.The Journal of Antimicrobial Chemotherapy|July 9, 2013
Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and BD B Fofana, C Soulie, A I Maiga, et al.The Journal of Antimicrobial Chemotherapy|May 28, 2016
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combinationS Lambert-Niclot, C Allavena, M Grude, et al.The Journal of Antimicrobial Chemotherapy|December 5, 2019
Long-term follow-up of HIV-infected patients on dolutegravir monotherapyG Tebano, C Soulié, L Schneider, et al.Infection|October 25, 2013
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity scoreF Caby, L Schneider, C Blanc, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 31, 2016
Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtypeC Soulié, D B Fofana, N Boukli, et al.The Journal of Antimicrobial Chemotherapy|December 8, 2017
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemiaS Seang, L Schneider, T Nguyen, et al.HIV Medicine|April 27, 2017
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populationsE Todesco, C Charpentier, M Bertine, et al.Pageof 7